american heart association glp-1 Glucagon-Like Peptide 1 Receptor Agonists and Failure GLP-1, SGLT2 medications may lower

doi: 10.1016/S0002-9378(96)70221-1 66 LedermanSARossoP

The gap between what BPC-157 does in a rat and what it does in a human is not a small gap

Best Uses for Supplements: Bridge therapy while waiting for prescription access, maintenance after stopping GLP-1 medications, natural alternative for those with mild overweight or pre-diabetes, or to ease side effects of prescription medications

Some reports expect the weight-loss market alone to reach US$ 100 billion by the end of the decade, while NASH has been estimated to be a US$ 35 billion opportunity

While some lean mass loss inevitably occurs during significant weight reduction, the rate is typically 20-25% of total weight lost on tirzepatide compared to 30-40% with diet-only approaches

The Hollywood Reporter